Study Summary
To observe the efficacy and side effects of autologous hematopoietic stem cell transplantation combined with CD19-CART for adult acute lymphoblastic leukemia, and to evaluate the safety and efficacy of this regimen in the treatment of acute lymphoblastic leukemia.
Want to learn more about this trial?
Request More InfoInterventions
Autologous hematopoietic stem cell transplantation combined with CD19-CARTBIOLOGICAL
Autologous CD19-CAR T cells were transfused +7 days after autologous hematopoietic stem cell transplantation
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| NO.288 Nanjing Road，Heping District，Tianjin, Tianjin, | Tianjin | Tianjin Municipality | China |